iodixanol
(NBQNWMBBSKPBAY-UHFFFAOYSA-N)
Structure
- SMILES
- OCC(CNC(=O)c1c(I)c(N(C(=O)C)CC(CN(c2c(I)c(C(=O)NCC(CO)O)c(c(c2I)C(=O)NCC(CO)O)I)C(=O)C)O)c(c(c1I)C(=O)NCC(CO)O)I)O
- Type(s)
- Approved
- ATC code(s)
- V08AB09
- Molecular Formula:
- C35H44I6N6O15
- Molecular Weight:
- 1550.180
- Log P:
- -0.0233
- Hydrogen Bond Acceptor:
- 21
- Hydrogen Bond Donor:
- 13
- TPSA:
- 339.09
- CAS Number(s):
- 92339-11-2
Synonym(s)
1.
iodixanol
2.
Visipaque
3.
Visipaque Unique Softpac
4.
contrast media 2-5410-3
5.
iodixanol-320
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Pruritus | FAERS: 154 Canada Vigilance: 62 | Canada Vigilance SIDER US FAERS | |
| 2 | Urticaria | FAERS: 127 Canada Vigilance: 95 | 9211770 | CTD SIDER Canada Vigilance US FAERS |
| 3 | Erythema | FAERS: 102 Canada Vigilance: 38 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 4 | Nausea | FAERS: 74 Canada Vigilance: 13 | 9211770 | CTD SIDER Canada Vigilance US FAERS |
| 5 | Vomiting | FAERS: 71 Canada Vigilance: 8 | Canada Vigilance SIDER US FAERS | |
| 6 | Hypotension | FAERS: 56 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 7 | Contrast media reaction | FAERS: 45 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 8 | Chills | FAERS: 44 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 9 | Flushing | FAERS: 36 Canada Vigilance: 5 | Canada Vigilance SIDER US FAERS | |
| 10 | Hypersensitivity | FAERS: 29 Canada Vigilance: 12 | Canada Vigilance US FAERS | |
| 11 | Angioedema | FAERS: 28 | SIDER US FAERS | |
| 12 | Chest discomfort | FAERS: 26 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 13 | Sneezing | FAERS: 25 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 14 | Cardiac Arrest | FAERS: 24 Canada Vigilance: 5 | Canada Vigilance SIDER US FAERS | |
| 15 | Headache | FAERS: 24 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 16 | Dizziness | FAERS: 22 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 17 | Tachycardia | FAERS: 21 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 18 | Anaphylactic shock | FAERS: 20 Canada Vigilance: 4 | Canada Vigilance SIDER US FAERS | |
| 19 | Blood creatinine increased | FAERS: 20 | OFFSIDES SIDER US FAERS | |
| 20 | Throat irritation | FAERS: 20 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 21 | Contrast media allergy | FAERS: 19 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 22 | Swelling | FAERS: 19 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 23 | Anaphylactoid Reaction | FAERS: 18 Canada Vigilance: 9 | Canada Vigilance SIDER US FAERS | |
| 24 | Cyanosis | FAERS: 17 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 25 | Malaise | FAERS: 17 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 26 | Tremor | FAERS: 17 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 27 | Bronchospasm | FAERS: 16 | SIDER US FAERS | |
| 28 | Syncope | FAERS: 16 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 29 | Chest Pain | FAERS: 15 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 30 | Extravasation | FAERS: 14 | US FAERS | |
| 31 | Post procedural complication | FAERS: 13 | OFFSIDES US FAERS | |
| 32 | Respiratory arrest | FAERS: 13 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 33 | Abdominal Pain | FAERS: 12 | SIDER US FAERS | |
| 34 | Asthenia | FAERS: 12 | SIDER US FAERS | |
| 35 | Shock | FAERS: 12 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 36 | Respiratory distress | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 37 | Aphasia | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 38 | Bradycardia | FAERS: 10 | OFFSIDES SIDER US FAERS | |
| 39 | Coronary no-reflow phenomenon | FAERS: 10 | US FAERS | |
| 40 | Respiratory Failure | FAERS: 10 | US FAERS | |
| 41 | Skin reaction | FAERS: 10 | US FAERS | |
| 42 | Unresponsive to stimuli | FAERS: 10 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 43 | Cold sweat | FAERS: 9 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 44 | Dysphonia | FAERS: 9 Canada Vigilance: 4 | Canada Vigilance OFFSIDES US FAERS | |
| 45 | Rash erythematous | FAERS: 9 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 46 | Renal tubular necrosis | FAERS: 9 | OFFSIDES US FAERS | |
| 47 | Back Pain | FAERS: 8 | SIDER US FAERS | |
| 48 | Palpitations | FAERS: 8 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 49 | Cerebrovascular accident | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 50 | Hemiparesis | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 51 | Myocardial Infarction | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 52 | Pain | FAERS: 7 Canada Vigilance: 1 | 9211770 | CTD OFFSIDES SIDER Canada Vigilance US FAERS |
| 53 | Ventricular Fibrillation | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 54 | Wheezing | FAERS: 7 | US FAERS | |
| 55 | Acute kidney injury | FAERS: 6 | CTD US FAERS | |
| 56 | Atrial Fibrillation | FAERS: 6 | SIDER US FAERS | |
| 57 | Lip swelling | FAERS: 6 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 58 | Procedural complication | FAERS: 6 | OFFSIDES US FAERS | |
| 59 | Urinary Incontinence | FAERS: 6 | US FAERS | |
| 60 | Acute myocardial infarction | FAERS: 5 | US FAERS | |
| 61 | Anuria | FAERS: 5 | OFFSIDES US FAERS | |
| 62 | Disorientation | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 63 | Erythema Multiforme | FAERS: 5 | US FAERS | |
| 64 | Infusion Site Extravasation | FAERS: 5 | US FAERS | |
| 65 | Injection site extravasation | FAERS: 5 | US FAERS | |
| 66 | No adverse event | FAERS: 5 | US FAERS | |
| 67 | Pallor | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 68 | Product quality issue | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 69 | Rhinitis | FAERS: 5 | OFFSIDES SIDER US FAERS | |
| 70 | Sepsis | FAERS: 5 | US FAERS | |
| 71 | Septic Shock | FAERS: 5 | US FAERS | |
| 72 | Abdominal discomfort | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 73 | Altered state of consciousness | FAERS: 4 | US FAERS | |
| 74 | Anxiety | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 75 | Contrast encephalopathy | FAERS: 4 | US FAERS | |
| 76 | Delirium | FAERS: 4 | US FAERS | |
| 77 | Discomfort | FAERS: 4 | SIDER US FAERS | |
| 78 | Dystonia | FAERS: 4 | US FAERS | |
| 79 | Eosinophilia | FAERS: 4 | US FAERS | |
| 80 | Fatigue | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 81 | Feeling Cold | FAERS: 4 | OFFSIDES US FAERS | |
| 82 | General physical health deterioration | FAERS: 4 | OFFSIDES US FAERS | |
| 83 | Hypoxia | FAERS: 4 | US FAERS | |
| 84 | Lethargy | FAERS: 4 | US FAERS | |
| 85 | Papule | FAERS: 4 | US FAERS | |
| 86 | Presyncope | FAERS: 4 | SIDER US FAERS | |
| 87 | Retching | FAERS: 4 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 88 | Vertigo | FAERS: 4 | SIDER US FAERS | |
| 89 | Aphonia | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 90 | Arthralgia | FAERS: 3 | SIDER US FAERS | |
| 91 | Burning sensation | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 92 | Cheilitis | FAERS: 3 | US FAERS | |
| 93 | Depressed Level of Consciousness | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 94 | Diplopia | FAERS: 3 | OFFSIDES SIDER US FAERS | |
| 95 | Drug administration error | FAERS: 3 | US FAERS | |
| 96 | Eye irritation | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 97 | Head discomfort | FAERS: 3 | US FAERS | |
| 98 | Klebsiella sepsis | FAERS: 3 | OFFSIDES US FAERS | |
| 99 | Laryngeal discomfort | FAERS: 3 | US FAERS | |
| 100 | Mental status changes | FAERS: 3 | OFFSIDES US FAERS | |
| 101 | Musculoskeletal stiffness | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 102 | Oropharyngeal pain | FAERS: 3 | US FAERS | |
| 103 | Peripheral swelling | FAERS: 3 | US FAERS | |
| 104 | Pneumonia | FAERS: 3 | US FAERS | |
| 105 | Pneumothorax | FAERS: 3 | US FAERS | |
| 106 | Productive Cough | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 107 | Respiratory Depression | FAERS: 3 | US FAERS | |
| 108 | Restlessness | FAERS: 3 | US FAERS | |
| 109 | Skin necrosis | FAERS: 3 | OFFSIDES US FAERS | |
| 110 | Stevens-Johnson Syndrome | FAERS: 3 | US FAERS | |
| 111 | Stridor | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 112 | Vasculitis | FAERS: 3 | US FAERS | |
| 113 | Visual Impairment | FAERS: 3 | SIDER US FAERS | |
| 114 | Acute respiratory failure | FAERS: 2 | US FAERS | |
| 115 | Agitation | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 116 | Amaurosis | FAERS: 2 | US FAERS | |
| 117 | Blepharitis | FAERS: 2 | US FAERS | |
| 118 | Blood brain barrier defect | FAERS: 2 | US FAERS | |
| 119 | Blood pressure fluctuation | FAERS: 2 | US FAERS | |
| 120 | Blood urea increased | FAERS: 2 | SIDER US FAERS | |
| 121 | Bronchial Obstruction | FAERS: 2 | US FAERS | |
| 122 | Cerebellar infarction | FAERS: 2 | US FAERS | |
| 123 | Cerebral Infarction | FAERS: 2 | US FAERS | |
| 124 | Cerebral artery occlusion | FAERS: 2 | US FAERS | |
| 125 | Cerebral atrophy | FAERS: 2 | US FAERS | |
| 126 | Choking sensation | FAERS: 2 | OFFSIDES US FAERS | |
| 127 | Coma scale abnormal | FAERS: 2 | US FAERS | |
| 128 | Conjunctivitis | FAERS: 2 | SIDER US FAERS | |
| 129 | Dehydration | FAERS: 2 | US FAERS | |
| 130 | Disease Progression | FAERS: 2 | US FAERS | |
| 131 | Documented hypersensitivity to administered drug | FAERS: 2 | US FAERS | |
| 132 | Drug clearance decreased | FAERS: 2 | US FAERS | |
| 133 | Drug ineffective | FAERS: 2 | US FAERS | |
| 134 | Dry skin | FAERS: 2 | SIDER US FAERS | |
| 135 | Electromechanical dissociation | FAERS: 2 | US FAERS | |
| 136 | Embolism | FAERS: 2 | US FAERS | |
| 137 | Feeling abnormal | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 138 | Fluid overload | FAERS: 2 | US FAERS | |
| 139 | Hemiplegia | FAERS: 2 | US FAERS | |
| 140 | Inflammation | FAERS: 2 | US FAERS | |
| 141 | Laryngospasm | FAERS: 2 | US FAERS | |
| 142 | Leukoaraiosis | FAERS: 2 | OFFSIDES US FAERS | |
| 143 | Leukocytosis | FAERS: 2 | US FAERS | |
| 144 | Lymphadenopathy | FAERS: 2 | US FAERS | |
| 145 | Macule | FAERS: 2 | US FAERS | |
| 146 | Metabolic acidosis | FAERS: 2 | US FAERS | |
| 147 | NIH stroke scale score increased | FAERS: 2 | US FAERS | |
| 148 | Nasal discomfort | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 149 | Nasal pruritus | FAERS: 2 | US FAERS | |
| 150 | Oropharyngeal discomfort | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 151 | Overdose | FAERS: 2 | US FAERS | |
| 152 | Pancreatitis | FAERS: 2 | US FAERS | |
| 153 | Petechiae | FAERS: 2 | US FAERS | |
| 154 | Pulmonary congestion | FAERS: 2 | OFFSIDES US FAERS | |
| 155 | Sense of oppression | FAERS: 2 | US FAERS | |
| 156 | Sinus Tachycardia | FAERS: 2 | US FAERS | |
| 157 | Systemic Inflammatory Response Syndrome | FAERS: 2 | US FAERS | |
| 158 | Thrombocytopenia | FAERS: 2 | US FAERS | |
| 159 | Unevaluable event | FAERS: 2 | US FAERS | |
| 160 | nervous system disorder | FAERS: 2 | SIDER US FAERS | |
| 161 | Abasia | FAERS: 1 | US FAERS | |
| 162 | Acidosis | FAERS: 1 | OFFSIDES SIDER US FAERS | |
| 163 | Acute prerenal failure | FAERS: 1 | US FAERS | |
| 164 | Ageusia | FAERS: 1 | US FAERS | |
| 165 | Alcohol withdrawal syndrome | FAERS: 1 | US FAERS | |
| 166 | Amaurosis Fugax | FAERS: 1 | US FAERS | |
| 167 | Ammonia increased | FAERS: 1 | OFFSIDES US FAERS | |
| 168 | Amnestic Disorder | FAERS: 1 | US FAERS | |
| 169 | Anal sphincter atony | FAERS: 1 | US FAERS | |
| 170 | Angina Pectoris | FAERS: 1 | 11578707 | CTD SIDER US FAERS |
| 171 | Antibiotic level above therapeutic | FAERS: 1 | US FAERS | |
| 172 | Aortic Aneurysm | FAERS: 1 | US FAERS | |
| 173 | Arthropathy | FAERS: 1 | US FAERS | |
| 174 | Asphyxia | FAERS: 1 | US FAERS | |
| 175 | Blindness | FAERS: 1 | US FAERS | |
| 176 | Blood glucose increased | FAERS: 1 | US FAERS | |
| 177 | Blood pressure immeasurable | FAERS: 1 | US FAERS | |
| 178 | Cardiac procedure complication | FAERS: 1 | OFFSIDES US FAERS | |
| 179 | Cataract | FAERS: 1 | US FAERS | |
| 180 | Chemical injury | FAERS: 1 | US FAERS | |
| 181 | Chloasma | FAERS: 1 | US FAERS | |
| 182 | Cholestasis | FAERS: 1 | US FAERS | |
| 183 | Deafness | FAERS: 1 | SIDER US FAERS | |
| 184 | Dermatitis | FAERS: 1 | SIDER US FAERS | |
| 185 | Device Failure | FAERS: 1 | US FAERS | |
| 186 | Device leakage | FAERS: 1 | US FAERS | |
| 187 | Disseminated Intravascular Coagulation | FAERS: 1 | US FAERS | |
| 188 | Documented hypersensitivity to administered product | FAERS: 1 | US FAERS | |
| 189 | Dysarthria | FAERS: 1 | US FAERS | |
| 190 | Ejection Fraction Decreased | FAERS: 1 | US FAERS | |
| 191 | Electrocardiogram ST segment abnormal | FAERS: 1 | US FAERS | |
| 192 | Embolic stroke | FAERS: 1 | US FAERS | |
| 193 | Exfoliative rash | FAERS: 1 | US FAERS | |
| 194 | Expired drug administered | FAERS: 1 | US FAERS | |
| 195 | Eye Infection | FAERS: 1 | US FAERS | |
| 196 | Eye pain | FAERS: 1 | US FAERS | |
| 197 | Eyelids pruritus | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 198 | Facial Paresis | FAERS: 1 | US FAERS | |
| 199 | Feeling jittery | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 200 | Fibrin D dimer increased | FAERS: 1 | US FAERS | |
| 201 | Foaming at mouth | FAERS: 1 | US FAERS | |
| 202 | Gastrointestinal Pain | FAERS: 1 | SIDER US FAERS | |
| 203 | General physical condition abnormal | FAERS: 1 | US FAERS | |
| 204 | Glossitis | FAERS: 1 | US FAERS | |
| 205 | Hepatitis | FAERS: 1 | US FAERS | |
| 206 | Hyperkeratosis | FAERS: 1 | US FAERS | |
| 207 | Hypersomnia | FAERS: 1 | US FAERS | |
| 208 | Hypertensive emergency | FAERS: 1 | US FAERS | |
| 209 | Hyperthyroidism | FAERS: 1 | US FAERS | |
| 210 | Hypocoagulable state | FAERS: 1 | US FAERS | |
| 211 | Hyporesponsive to stimuli | FAERS: 1 | US FAERS | |
| 212 | Hypotonic-hyporesponsive episode | FAERS: 1 | US FAERS | |
| 213 | Ileus | FAERS: 1 | US FAERS | |
| 214 | Incontinence | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 215 | Increased upper airway secretion | FAERS: 1 | US FAERS | |
| 216 | Infarction | FAERS: 1 | US FAERS | |
| 217 | Infusion site erythema | FAERS: 1 | US FAERS | |
| 218 | Infusion site induration | FAERS: 1 | US FAERS | |
| 219 | Injection related reaction | FAERS: 1 | US FAERS | |
| 220 | Injection site erythema | FAERS: 1 | US FAERS | |
| 221 | Intracranial Hypotension | FAERS: 1 | US FAERS | |
| 222 | Large intestine perforation | FAERS: 1 | US FAERS | |
| 223 | Lip pruritus | FAERS: 1 | US FAERS | |
| 224 | Liquid product physical issue | FAERS: 1 | US FAERS | |
| 225 | Lobar Pneumonia | FAERS: 1 | US FAERS | |
| 226 | Lymphadenitis | FAERS: 1 | US FAERS | |
| 227 | Medication Error | FAERS: 1 | US FAERS | |
| 228 | Memory impairment | FAERS: 1 | US FAERS | |
| 229 | Mental impairment | FAERS: 1 | US FAERS | |
| 230 | Muscle Cramp | FAERS: 1 | US FAERS | |
| 231 | Muscle tightness | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 232 | Mydriasis | FAERS: 1 | US FAERS | |
| 233 | Nasopharyngitis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 234 | Neck Pain | FAERS: 1 | US FAERS | |
| 235 | Nephrectomy | FAERS: 1 | US FAERS | |
| 236 | Nephrotic Syndrome | FAERS: 1 | US FAERS | |
| 237 | Neutrophil percentage increased | FAERS: 1 | US FAERS | |
| 238 | No reaction on previous exposure to drug | FAERS: 1 | US FAERS | |
| 239 | Noninfective sialoadenitis | FAERS: 1 | US FAERS | |
| 240 | Nonspecific reaction | FAERS: 1 | US FAERS | |
| 241 | Occupational exposure to product | FAERS: 1 | US FAERS | |
| 242 | Ocular icterus | FAERS: 1 | US FAERS | |
| 243 | Osteomyelitis | FAERS: 1 | US FAERS | |
| 244 | Oxygen saturation abnormal | FAERS: 1 | OFFSIDES US FAERS | |
| 245 | Oxygen supplementation | FAERS: 1 | US FAERS | |
| 246 | Pancreatic Fistula | FAERS: 1 | US FAERS | |
| 247 | Pancreatic carcinoma | FAERS: 1 | US FAERS | |
| 248 | Pancytopenia | FAERS: 1 | US FAERS | |
| 249 | Paraplegia | FAERS: 1 | US FAERS | |
| 250 | Peritonitis | FAERS: 1 | US FAERS | |
| 251 | Procedural hypotension | FAERS: 1 | US FAERS | |
| 252 | Purpura | FAERS: 1 | US FAERS | |
| 253 | Respiratory tract inflammation | FAERS: 1 | US FAERS | |
| 254 | Rhabdomyolysis | FAERS: 1 | US FAERS | |
| 255 | Salmonella test positive | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 256 | Seizure like phenomena | FAERS: 1 | US FAERS | |
| 257 | Sinus bradycardia | FAERS: 1 | SIDER US FAERS | |
| 258 | Skin lesion | FAERS: 1 | US FAERS | |
| 259 | Skin test positive | FAERS: 1 | US FAERS | |
| 260 | Skin tightness | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 261 | Somnolence | FAERS: 1 | SIDER US FAERS | |
| 262 | Sopor | FAERS: 1 | US FAERS | |
| 263 | Stroke in evolution | FAERS: 1 | US FAERS | |
| 264 | Sudden death | FAERS: 1 | US FAERS | |
| 265 | Superinfection | FAERS: 1 | US FAERS | |
| 266 | Supraventricular tachycardia | FAERS: 1 | US FAERS | |
| 267 | Symmetrical drug-related intertriginous and flexural exanthema | FAERS: 1 | US FAERS | |
| 268 | Therapeutic product contamination | FAERS: 1 | US FAERS | |
| 269 | Therapy non-responder | FAERS: 1 | US FAERS | |
| 270 | Tinnitus | FAERS: 1 | SIDER US FAERS | |
| 271 | Tongue pruritus | FAERS: 1 | US FAERS | |
| 272 | Toxic Epidermal Necrolysis | FAERS: 1 | US FAERS | |
| 273 | Transaminases increased | FAERS: 1 | US FAERS | |
| 274 | Troponin increased | FAERS: 1 | US FAERS | |
| 275 | Tryptase increased | FAERS: 1 | US FAERS | |
| 276 | Upper motor neurone lesion | FAERS: 1 | US FAERS | |
| 277 | Upper respiratory tract congestion | FAERS: 1 | US FAERS | |
| 278 | Upper-airway cough syndrome | FAERS: 1 | US FAERS | |
| 279 | Urinary hesitation | FAERS: 1 | US FAERS | |
| 280 | Urinary tract infection | FAERS: 1 | SIDER US FAERS | |
| 281 | Vascular purpura | FAERS: 1 | US FAERS | |
| 282 | Vascular rupture | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 283 | Abnormal vision | SIDER | ||
| 284 | Acne | OFFSIDES | ||
| 285 | Acute Coronary Syndrome | SIDER | ||
| 286 | Alanine Aminotransferase Increased | OFFSIDES | ||
| 287 | Amnesia | SIDER | ||
| 288 | Anosognosia | SIDER | ||
| 289 | Anoxia | SIDER | ||
| 290 | Antiphospholipid antibodies positive | OFFSIDES | ||
| 291 | Apathy | OFFSIDES | ||
| 292 | Ascites | OFFSIDES | ||
| 293 | Asthenic conditions | SIDER | ||
| 294 | Asthma | SIDER | ||
| 295 | Blood Glucose | OFFSIDES | ||
| 296 | Body Temperature | OFFSIDES | ||
| 297 | Bone lesion | OFFSIDES | ||
| 298 | Bronchitis | SIDER | ||
| 299 | Catatonia | Canada Vigilance: 1 | Canada Vigilance | |
| 300 | Cerebellar Ataxia | OFFSIDES | ||
| 301 | Choking | Canada Vigilance: 2 | Canada Vigilance | |
| 302 | Chronic Obstructive Airway Disease | OFFSIDES | ||
| 303 | Chronic sinusitis | OFFSIDES | ||
| 304 | Coagulation factor VIII level increased | OFFSIDES | ||
| 305 | Colitis | OFFSIDES | ||
| 306 | Confabulation | OFFSIDES | ||
| 307 | Contracture | OFFSIDES | ||
| 308 | Cramps of lower extremities | SIDER | ||
| 309 | Creatinine renal clearance decreased | OFFSIDES | ||
| 310 | Demyelination | OFFSIDES | ||
| 311 | Dental abscess | OFFSIDES | ||
| 312 | Distress | SIDER | ||
| 313 | Diverticulum | OFFSIDES | ||
| 314 | Drowsiness | SIDER | ||
| 315 | Dysgeusia | OFFSIDES SIDER | ||
| 316 | Dyspepsia | OFFSIDES SIDER | ||
| 317 | Dyspnea | 8761866 11578707 | CTD | |
| 318 | Ear discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 319 | Emotional distress | OFFSIDES SIDER | ||
| 320 | Epidermal necrosis | OFFSIDES | ||
| 321 | Epilepsy | SIDER | ||
| 322 | Esophageal Stenosis | OFFSIDES | ||
| 323 | General physical condition | OFFSIDES | ||
| 324 | Granulocytosis | OFFSIDES | ||
| 325 | Heart Diseases | 19021282 | CTD | |
| 326 | Hyperpigmentation | OFFSIDES | ||
| 327 | Hyperventilation | Canada Vigilance: 1 | Canada Vigilance | |
| 328 | Hypokinesia | SIDER | ||
| 329 | Hypophagia | OFFSIDES | ||
| 330 | Idiopathic urticaria | OFFSIDES | ||
| 331 | Infusion site mobility decreased | OFFSIDES | ||
| 332 | Injection Site Reaction | SIDER | ||
| 333 | Injection site inflammation | SIDER | ||
| 334 | Injection site pain | SIDER | ||
| 335 | Joint Range of Motion Decreased | OFFSIDES | ||
| 336 | Kidney Diseases |
15926184
16502177 16528264 17035872 17140161 17562951 17882021 18301313 18415784 18771430 19021282 19288321 20031753 | CTD | |
| 337 | Life expectancy shortened | OFFSIDES | ||
| 338 | Loose tooth | OFFSIDES | ||
| 339 | Metastatic Neoplasm | OFFSIDES | ||
| 340 | Morphea | OFFSIDES | ||
| 341 | Mouth swelling | Canada Vigilance: 1 | Canada Vigilance | |
| 342 | Musculoskeletal discomfort | SIDER | ||
| 343 | Nephrogenic Fibrosing Dermopathy | OFFSIDES | ||
| 344 | Nervousness | SIDER | ||
| 345 | Oliguria | OFFSIDES | ||
| 346 | Ophthalmoplegia | OFFSIDES | ||
| 347 | Periarthritis | OFFSIDES | ||
| 348 | Pharyngeal swelling | Canada Vigilance: 2 | Canada Vigilance | |
| 349 | Pharyngitis | SIDER | ||
| 350 | Pleurectomy | OFFSIDES | ||
| 351 | Polymyalgia Rheumatica | SIDER | ||
| 352 | Polyneuropathy | OFFSIDES | ||
| 353 | Precordial pain | SIDER | ||
| 354 | Psoriasis | OFFSIDES | ||
| 355 | Pyuria | OFFSIDES | ||
| 356 | Rectal Prolapse | OFFSIDES | ||
| 357 | Renal Insufficiency | 17003814 18256017 | CTD | |
| 358 | Scotoma | SIDER | ||
| 359 | Secretion discharge | OFFSIDES | ||
| 360 | Seizures | 8761866 | CTD | |
| 361 | Sensation of warmth | SIDER | ||
| 362 | Sinusitis | SIDER | ||
| 363 | Skin Induration | OFFSIDES | ||
| 364 | Skin hypertrophy | OFFSIDES | ||
| 365 | Spinal vascular disorder | OFFSIDES | ||
| 366 | Stupor | SIDER | ||
| 367 | Swelling of eyelid | Canada Vigilance: 1 | Canada Vigilance | |
| 368 | Tension | SIDER | ||
| 369 | Thrombophlebitis | SIDER | ||
| 370 | Thrombosis | SIDER | ||
| 371 | Tooth Extraction | OFFSIDES | ||
| 372 | Toxicity to various agents | SIDER | ||
| 373 | Urethritis | OFFSIDES | ||
| 374 | Venous Insufficiency | OFFSIDES | ||
| 375 | Ventricular arrhythmia | SIDER | ||
| 376 | intensive care | Canada Vigilance: 1 | Canada Vigilance | |
| 377 | treatment failure | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.